East Bay Parkinson's drug maker to be swallowed up in potential $450M deal

The acquisition, expected to close by the end of this year or early 2022, includes $400 million in upfront payments.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news